Back

Persistence of guideline-directed medical therapy after heart failure hospitalisation in older adults with cancer

29 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Managing heart failure across the cancer continuum: from risk prediction to survivorship Cardio-Oncology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Kyohei Daigo

Tokyo (Japan)

6 More presentations in this session

Presentation thumbnail
Risk-guided disease management to prevent heart failure in adult cancer survivors of previous cardiotoxic cancer treatments (REDEEM) trial
Doctor J. Wong (Melbourne, AU)
Abstract
Presentation thumbnail
Quality of care and clinical outcomes in cancer patients presenting with acute heart failure
Doctor A. Cannata (London, GB)
Abstract
Presentation thumbnail
A scalable electronic medical record–based risk score for predicting heart failure in cancer survivors: external validation of CHERISH
Doctor C. Soh (Melbourne, AU)
Abstract
Presentation thumbnail
Risk stratification and shap-derived mortality phenotypes in AMI and heart failure with breast/prostate cancer: NIS 2018–2022
Ms V. Godishala (Newark, US)
Abstract
Presentation thumbnail
Prediction and personalized interpretation of risk for multiple cancer outcomes in patients with heart failure: a machine learning study
Miss Y. Qi (HK)
Abstract

Access the full session

Session thumbnail
Managing heart failure across the cancer continuum: from risk prediction to survivorship

The Event

Event poster

ESC Congress 2026

29 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Discontinuation of guideline-recommended heart failure treatments after a first hospitalization for heart failure - An analysis from the SwedeHF registry
21 May 2022
thumbnail
Congress Presentation
Impact of sodium-glucose cotransporter-2 inhibitors on survival in patients with cancer therapy-related cardiac dysfunction
20 June 2025
thumbnail
Congress Presentation
Association of cancer history and physical function with prognosis in heart failure patients
20 May 2023
thumbnail
Congress Presentation
Use of guideline directed medical therapy and clinical outcomes in cancer patients with de novo heart failure
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources